Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Cooper

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2017
Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damageJinwen Tu, Shihani Stoner, Phillip D Fromm, et al.
The American Journal of Pathology|March 19, 2016
Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced ArthritisJinwen Tu, Yaqing Zhang, Sarah Kim, et al.
Endocrine Reviews|October 7, 2004
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid responseJeremy W Tomlinson, Elizabeth A Walker, Iwona J Bujalska, et al.
Calcified Tissue International|June 23, 2011
Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?Mark S Cooper, Hashir Kriel, Adrian Sayers, et al.
Arthritis Research & Therapy|October 20, 2012
Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritisRowan Hardy, Maria Juarez, Amy Naylor, et al.
Bone|September 7, 2014
Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone developmentJinwen Tu, Holger Henneicke, Yaqing Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal OsteopeniaAfroze Abbas, Marian Schini, Gemma Ainsworth, et al.
The Medical Journal of Australia|September 9, 2020
Cumulative dispensing of high oral corticosteroid doses for treating asthma in AustraliaMark Hew, Vanessa M McDonald, Phil G Bardin, et al.
Burns & Trauma|June 17, 2026
Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scarsJuntong Guo, Qinghan Tang, Zhengping Ge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 yearsZaki K Hassan-Smith, Mark Sherlock, Raoul C Reulen, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2017
Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damageJinwen Tu, Shihani Stoner, Phillip D Fromm, et al.
The American Journal of Pathology|March 19, 2016
Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced ArthritisJinwen Tu, Yaqing Zhang, Sarah Kim, et al.
Endocrine Reviews|October 7, 2004
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid responseJeremy W Tomlinson, Elizabeth A Walker, Iwona J Bujalska, et al.
Calcified Tissue International|June 23, 2011
Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?Mark S Cooper, Hashir Kriel, Adrian Sayers, et al.
Arthritis Research & Therapy|October 20, 2012
Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritisRowan Hardy, Maria Juarez, Amy Naylor, et al.
Bone|September 7, 2014
Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone developmentJinwen Tu, Holger Henneicke, Yaqing Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal OsteopeniaAfroze Abbas, Marian Schini, Gemma Ainsworth, et al.
The Medical Journal of Australia|September 9, 2020
Cumulative dispensing of high oral corticosteroid doses for treating asthma in AustraliaMark Hew, Vanessa M McDonald, Phil G Bardin, et al.
Burns & Trauma|June 17, 2026
Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scarsJuntong Guo, Qinghan Tang, Zhengping Ge, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 yearsZaki K Hassan-Smith, Mark Sherlock, Raoul C Reulen, et al.
Pageof 11